Home / Inspections / 1309914

FDA Inspection 1309914 — UC Reproductive Medicine at Kettering

UC Reproductive Medicine at Kettering — FEI 3003928248

The FDA completed an inspection of UC Reproductive Medicine at Kettering on March 23, 2026 in Kettering, OH. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 23, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Kettering, OH (United States)

Facility

Other inspections at this facility

  • 1150253 (NAI Wed Aug 25 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1054286 (NAI Wed May 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 954467 (NAI Thu Jan 07 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 861701 (NAI Wed Jan 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 766662 (NAI Wed Jan 18 2012 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources